Blume Capital Management, Inc. Bristol Myers Squibb CO Transaction History
Blume Capital Management, Inc.
- $428 Million
- Q4 2024
A detailed history of Blume Capital Management, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Blume Capital Management, Inc. holds 2,204 shares of BMY stock, worth $123,291. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,204
Previous 2,204
-0.0%
Holding current value
$123,291
Previous $114,000
8.77%
% of portfolio
0.03%
Previous 0.03%
Shares
14 transactions
Others Institutions Holding BMY
# of Institutions
2,671Shares Held
1.47BCall Options Held
31.9MPut Options Held
35.3M-
Vanguard Group Inc Valley Forge, PA190MShares$10.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.88 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.2 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.36 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.37 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...